Follow
Luis Tercedor Sánchez
Luis Tercedor Sánchez
Cardiologist. University Hospital Virgen de las Nieves. Granada. Spain
Verified email at juntadeandalucia.es
Title
Cited by
Cited by
Year
Mechanism of syncope in patients with heart disease and negative electrophysiologic test
C Menozzi, M Brignole, R Garcia-Civera, A Moya, G Botto, L Tercedor, ...
Circulation 105 (23), 2741-2745, 2002
2682002
Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF …
F Atienza, J Almendral, JM Ormaetxe, A Moya, JD Martínez-Alday, ...
Journal of the American College of Cardiology 64 (23), 2455-2467, 2014
2372014
Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators
J Villacastı́n, J Almendral, A Arenal, J Albertos, J Ormaetxe, R Peinado, ...
Circulation 93 (4), 753-762, 1996
1961996
The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases
E Sanchez-Rodriguez, A Egea-Zorrilla, J Plaza-Díaz, J Aragón-Vela, ...
Nutrients 12 (3), 605, 2020
1652020
Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF
SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ...
Journal of the American Heart Association 5 (3), e002197, 2016
1622016
Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation: results of a randomized, double-blind, controlled study
J Azpitarte, M Alvarez, R Baün, R Garcia, E Moreno, F Martin, L Tercedor, ...
European heart journal 18 (10), 1649-1654, 1997
1581997
Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance
M Álvarez, L Tercedor, I Almansa, N Ros, RS Galdeano, F Burillo, ...
Heart Rhythm 6 (12), 1714-1720, 2009
1042009
Novel desmin mutation p. Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy/dysplasia
FJ Bermúdez-Jiménez, V Carriel, A Brodehl, M Alaminos, A Campos, ...
Circulation 137 (15), 1595-1610, 2018
982018
Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia
Á Arenal, P Ávila, J Jiménez-Candil, L Tercedor, D Calvo, F Arribas, ...
Journal of the American College of Cardiology 79 (15), 1441-1453, 2022
942022
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial …
M Proietti, GYH Lip, C Laroche, L Fauchier, F Marin, M Nabauer, ...
EP Europace 23 (2), 174-183, 2021
902021
Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry
JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ...
Circulation 139 (6), 787-798, 2019
802019
A proposal for an appropriate central obesity diagnosis in Latin American population
RG Garcia, AE Cifuentes, RS Caballero, L Sanchez, P López-Jaramillo
International journal of cardiology 110 (2), 263-264, 2006
772006
Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope
A Moya, M Brignole, R Sutton, C Menozzi, R Garcia-Civera, W Wieling, ...
The American journal of cardiology 102 (11), 1518-1523, 2008
732008
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ...
EP Europace 21 (7), 1013-1022, 2019
662019
Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry
S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ...
Journal of the American Heart Association 8 (3), e010510, 2019
602019
Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy …
A Berruezo, J Acosta, J Fernández-Armenta, A Pedrote, A Barrera, ...
Europace 19 (4), 607-616, 2017
582017
Diagnostic approach to unexplained cardiac arrest (from the FIVI-Gen Study)
J Jiménez-Jáimez, R Peinado, EZ Grima, F Segura, P Moriña, JJS Muñoz, ...
The American Journal of Cardiology 116 (6), 894-899, 2015
562015
Clinical recognition of pure premature ventricular complex-induced cardiomyopathy at presentation
D Penela, J Fernández-Armenta, L Aguinaga, L Tercedor, A Ordoñez, ...
Heart Rhythm 14 (12), 1864-1870, 2017
552017
Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension
J Almendral, JP Villacastin, A Arenal, L Tercedor, JL Merino, JL Delcan
The American journal of cardiology 76 (13), 60D-63D, 1995
531995
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype–phenotype correlation study
D Segura-Rodríguez, FJ Bermúdez-Jiménez, V Carriel, ...
European Heart Journal-Cardiovascular Imaging 21 (4), 378-386, 2020
472020
The system can't perform the operation now. Try again later.
Articles 1–20